Jiyang Lv

553 total citations
23 papers, 383 citations indexed

About

Jiyang Lv is a scholar working on Molecular Biology, Rheumatology and Immunology. According to data from OpenAlex, Jiyang Lv has authored 23 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Rheumatology and 6 papers in Immunology. Recurrent topics in Jiyang Lv's work include Microbial Metabolic Engineering and Bioproduction (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Inflammasome and immune disorders (3 papers). Jiyang Lv is often cited by papers focused on Microbial Metabolic Engineering and Bioproduction (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Inflammasome and immune disorders (3 papers). Jiyang Lv collaborates with scholars based in China, Hong Kong and United States. Jiyang Lv's co-authors include Zixin Deng, Hairong Cheng, Shuangjun Lin, Ben Wang, Hengwei Wang, Mingguo Jiang, Meiying Wang, Yuxin Liao, Qingwen Wang and Fei Liu and has published in prestigious journals such as Bioinformatics, The Journal of Immunology and Journal of Agricultural and Food Chemistry.

In The Last Decade

Jiyang Lv

21 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiyang Lv China 12 213 114 47 46 44 23 383
Zhenglai Hua China 10 186 0.9× 66 0.6× 62 1.3× 43 0.9× 86 2.0× 12 397
Xuewei Yin China 13 128 0.6× 38 0.3× 80 1.7× 26 0.6× 49 1.1× 31 364
Crina Stăvaru Romania 12 159 0.7× 39 0.3× 122 2.6× 36 0.8× 28 0.6× 27 480
Shye‐Jye Tang Taiwan 12 220 1.0× 68 0.6× 110 2.3× 31 0.7× 89 2.0× 25 471
Peyman Ezzati Canada 15 397 1.9× 95 0.8× 104 2.2× 15 0.3× 30 0.7× 24 672
Yong Ying China 12 218 1.0× 26 0.2× 80 1.7× 52 1.1× 26 0.6× 25 456
Yuta Katsumata Japan 8 205 1.0× 29 0.3× 59 1.3× 38 0.8× 50 1.1× 12 376
Haijun Liu China 10 346 1.6× 62 0.5× 52 1.1× 12 0.3× 51 1.2× 13 506
Kanako Itohiya Japan 6 225 1.1× 26 0.2× 57 1.2× 43 0.9× 48 1.1× 10 405
Xiaoqin Fan China 13 239 1.1× 39 0.3× 57 1.2× 13 0.3× 104 2.4× 28 430

Countries citing papers authored by Jiyang Lv

Since Specialization
Citations

This map shows the geographic impact of Jiyang Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiyang Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiyang Lv more than expected).

Fields of papers citing papers by Jiyang Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiyang Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiyang Lv. The network helps show where Jiyang Lv may publish in the future.

Co-authorship network of co-authors of Jiyang Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Jiyang Lv. A scholar is included among the top collaborators of Jiyang Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiyang Lv. Jiyang Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lv, Jiyang, Junya Zhang, & Fangfang Wu. (2024). Clinical value of KiSS-1 and MMP-2 expression levels in breast cancer tissuein evaluating prognosis of elderly breast cancer patients after modified radicalmastectomy. Cellular and Molecular Biology. 70(3). 254–259. 1 indexed citations
2.
Li, Zihua, Hengli Lu, Jiyang Lv, et al.. (2024). Blocking CXCR4CARM1YAP axis overcomes osteosarcoma doxorubicin resistance by suppressing aerobic glycolysis. Cancer Science. 115(10). 3305–3319. 4 indexed citations
3.
Wang, Hongli, Jiyang Lv, Juan He, et al.. (2023). The prevalence and effects of treatments of rapidly progressive interstitial lung disease of dermatomyositis/polymyositis adults: A systematic review and meta-analysis. Autoimmunity Reviews. 22(8). 103335–103335. 7 indexed citations
4.
Zhao, Chenyang, Yusen Zhang, Qian Dong, et al.. (2023). Ultrasound Assessment of Entheseal Sites and Anterior Chest Wall in Ankylosing Spondylitis: A Cross‐Sectional Study. Journal of Ultrasound in Medicine. 42(11). 2535–2545. 3 indexed citations
5.
Lv, Jiyang, et al.. (2023). Sequence-based machine learning method for predicting the effects of phosphorylation on protein-protein interactions. International Journal of Biological Macromolecules. 243. 125233–125233. 10 indexed citations
6.
Li, Ningshan, Jiyang Lv, Yan Zhang, et al.. (2022). PTMint database of experimentally verified PTM regulation on protein–protein interaction. Bioinformatics. 39(1). 14 indexed citations
7.
Zhao, Na, Wenjuan Dong, Ha-Jeong Kim, et al.. (2020). Capping protein regulator and myosin 1 linker 3 regulates transcription of key cytokines in activated phagocytic cells. Cellular Signalling. 78. 109848–109848.
8.
Chi, Ping, et al.. (2020). L-Xylo-3-hexulose, a new rare sugar produced by the action of acetic acid bacteria on galactitol, an exception to Bertrand Hudson's rule. Biochimica et Biophysica Acta (BBA) - General Subjects. 1865(1). 129740–129740. 3 indexed citations
9.
Wang, Han, Yuxuan Wang, Hua Ye, et al.. (2019). Frequencies of the LILRA3 6.7-kb Deletion Are Highly Differentiated Among Han Chinese Subpopulations and Involved in Ankylosing Spondylitis Predisposition. Frontiers in Genetics. 10. 869–869. 7 indexed citations
10.
Wang, Meiying, Peng Zhang, Jiyang Lv, et al.. (2019). Heparin and aspirin combination therapy restores T-cell phenotype in pregnant patients with antiphospholipid syndrome-related recurrent pregnancy loss. Clinical Immunology. 208. 108259–108259. 13 indexed citations
11.
Liao, Yuxin, et al.. (2019). Targeting autophagy is a promising therapeutic strategy to overcome chemoresistance and reduce metastasis in osteosarcoma. International Journal of Oncology. 55(6). 1213–1222. 46 indexed citations
12.
Sun, Xiaolin, Jiyang Lv, Meiying Wang, et al.. (2018). Loss of Smad7 Promotes Inflammation in Rheumatoid Arthritis. Frontiers in Immunology. 9. 2537–2537. 29 indexed citations
13.
Borisjuk, Nikolai, Jiyang Lv, Guorun Qu, et al.. (2018). Structural and Biochemical Properties of Duckweed Surface Cuticle. Frontiers in Chemistry. 6. 317–317. 28 indexed citations
14.
Kim, Ha-Jeong, et al.. (2018). Golgi Phosphoprotein 2 Is a Novel Regulator of IL-12 Production and Macrophage Polarization. The Journal of Immunology. 200(4). 1480–1488. 10 indexed citations
15.
Wang, Meiying, et al.. (2017). Curcumin modulation of the activation of PYK2 in peripheral blood mononuclear cells from patients with lupus nephritis. Reumatologia/Rheumatology. 55(6). 269–275. 13 indexed citations
16.
Wang, Meiying, et al.. (2017). Analysis of clinical features and prognostic factors in Chinese patients with rheumatic diseases in an intensive care unit. The Egyptian Rheumatologist. 40(1). 63–66. 6 indexed citations
18.
Cheng, Hairong, Jiyang Lv, Hengwei Wang, et al.. (2014). Genetically engineered Pichia pastoris yeast for conversion of glucose to xylitol by a single-fermentation process. Applied Microbiology and Biotechnology. 98(8). 3539–3552. 35 indexed citations
19.
Cheng, Hairong, Ben Wang, Jiyang Lv, et al.. (2011). Xylitol production from xylose mother liquor: a novel strategy that combines the use of recombinant Bacillus subtilis and Candida maltosa. Microbial Cell Factories. 10(1). 5–5. 55 indexed citations
20.
Cheng, Hairong, Hengwei Wang, Jiyang Lv, et al.. (2011). A novel method to prepare L-Arabinose from xylose mother liquor by yeast-mediated biopurification. Microbial Cell Factories. 10(1). 43–43. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026